The Journal
Written by: PBL Magazine | Published On: February 18, 2025
ACRE Secures UK Distribution Rights for Galderma
ACRE, a trusted leader in medical aesthetics distribution, is delighted to announce its appointment as official UK distributor for Galderma, the world’s largest independent dermatology company.
This highly anticipated partnership marks a significant milestone in ACRE’s journey and underscores the brand’s reputation for innovation, quality, and leadership within the medical aesthetics industry.
Founded in 2018, ACRE is a subsidiary of CST Pharma Group Holdings, a leading contributor to the NHS supply chain. CST Pharma, an MHRA-regulated medicines wholesaler, holds over 200 NHS hospital contracts across England, Scotland, and Wales. During the COVID-19 pandemic, CST played a crucial role in providing essential treatments with significant cost savings to the NHS. Separately, CST has been recognised in the NHS 75th-anniversary publication as one of its leading suppliers, highlighting its longstanding contributions to the healthcare system.
ACRE’s commitment to putting patient safety first in combination with responsible supply of products is their cultural bedrock.
Since entering the aesthetics field, ACRE have focused on integrating their pharma heritage, standards and expertise into the industry. At the same time demonstrating an unwavering commitment to advancing patient care, safety, and clinical excellence.
ACRE’s partnership with Galderma further cements its role as a leader within its field; reinforcing ACRE’s mission but also highlighting its growing influence in shaping the future of the aesthetics industries.
Neil Clarkson, Co-Founder of ACRE, commented: “This truly is a monumental moment for ACRE. Our partnership with Galderma is the culmination of years of hard work and dedication and it really is testament to the team here at ACRE, our stringent processes and the wonderful community who trust us each and every day.
“Galderma’s portfolio represents the gold standard in skin health, and we are honoured to bring these solutions to the UK market. We look forward to supporting practitioners and patients alike with a portfolio that truly makes a difference.”
Galderma’s extensive product portfolio, including renowned brands such as Azzalure, Restylane and Sculptra offers cutting-edge solutions for dermatology, aesthetics, and skincare. As an official UK distributor, ACRE will ensure these pioneering products are readily accessible to healthcare professionals, enhancing patient outcomes nationwide.
